Targeting cancer cells through autophagy for anticancer therapy

Current Opinion in Cell Biology

Volumn 22, Issue 2, 2010, Pages 246-251

  Turcotte, Sandra ^a   Giaccia, Amato J ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTINEOPLASTIC AGENT; BECLIN 1; CHLOROQUINE; EVEROLIMUS; HYDROXYCHLOROQUINE; HYPOXIA INDUCIBLE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; N (3 METHYLPHENYL) 4 (4 PYRIDINYL) 2 THIAZOLAMINE; NICLOSAMIDE; PERHEXILINE; PROTEIN P53; ROTTLERIN; SMALL INTERFERING RNA; TEMSIROLIMUS;

AUTOPHAGY; CANCER CELL; CANCER THERAPY; DRUG CYTOTOXICITY; DRUG TARGETING; HUMAN; KIDNEY CARCINOMA; LYSOSOME; METABOLIC STRESS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASMS;

EID: 77951247552     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2009.12.007     Document Type: Review

References (58)

1. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
2. Klionsky D.J., Cregg J.M., Dunn W.A., Emr S.D., Sakai Y., Sandoval I.V., Sibirny A., Subramani S., Thumm M., Veenhuis M., et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003, 5:539-545.
3. Ichimura Y., Kirisako T., Takao T., Satomi Y., Shimonishi Y., Ishihara N., Mizushima N., Tanida I., Kominami E., Ohsumi M., et al. A ubiquitin-like system mediates protein lipidation. Nature 2000, 408:488-492.
4. Simonsen A., Tooze S.A. Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 2009, 186:773-782.
5. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005, 5:726-734.
6. Kundu M., Thompson C.B. Autophagy: basic principles and relevance to disease. Annu Rev Pathol 2008, 3:427-455.
7. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
8. Mathew R., Karantza-Wadsworth V., White E. Role of autophagy in cancer. Nat Rev Cancer 2007, 7:961-967.
9. Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., Mukherjee C., Shi Y., Gelinas C., Fan Y., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.
10. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by Beclin 1. Nature 1999, 402:672-676.
11. Aita V.M., Liang X.H., Murty V.V., Pincus D.L., Yu W., Cayanis E., Kalachikov S., Gilliam T.C., Levine B. Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
12. Yue Z., Jin S., Yang C., Levine A.J. Heintz N: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003, 100:15077-15082.
13. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., Rosen J., Eskelinen E.L., Mizushima N., Ohsumi Y., et al. Promotion of tumorigenesis by heterozygous disruption of the Beclin 1 autophagy gene. J Clin Invest 2003, 112:1809-1820.
14. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
15. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., Jung J.U. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006, 8:688-699.
16. Takahashi Y., Coppola D., Matsushita N., Cualing H.D., Sun M., Sato Y., Liang C., Jung J.U., Cheng J.Q., Mule J.J., et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007, 9:1142-1151.
17. Corcelle E.A., Puustinen P., Jaattela M Apoptosis and autophagy: targeting autophagy signalling in cancer cells-'trick or treats'?. FEBS J 2009, 276:6084-6096.
18. Sarbassov D.D., Ali S.M., Sabatini D.M. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005, 17:596-603.
19. Chan E.Y., Kir S., Tooze S.A. siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy. J Biol Chem 2007, 282:25464-25474.
20. Feng Z., Zhang H., Levine A.J., Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A 2005, 102:8204-8209.
21. Crighton D., Wilkinson S., O'Prey J., Syed N., Smith P., Harrison P.R., Gasco M., Garrone O., Crook T., Ryan K.M. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006, 126:121-134.
22. Tasdemir E., Maiuri M.C., Galluzzi L., Vitale I., Djavaheri-Mergny M., D'Amelio M., Criollo A., Morselli E., Zhu C., Harper F., et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 2008, 10:676-687.
23. Gozuacik D., Kimchi A. DAPk protein family and cancer. Autophagy 2006, 2:74-79.
24. Gozuacik D., Bialik S., Raveh T., Mitou G., Shohat G., Sabanay H., Mizushima N., Yoshimori T., Kimchi A. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ 2008, 15:1875-1886.
25. Zalckvar E., Berissi H., Eisenstein M., Kimchi A. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy 2009, 5:720-722.
26. Liang C., Lee J.S., Inn K.S., Gack M.U., Li Q., Roberts E.A., Vergne I., Deretic V., Feng P., Akazawa C., et al. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol 2008, 10:776-787.
27. Rusten T.E., Stenmark H. How do ESCRT proteins control autophagy?. J Cell Sci 2009, 122:2179-2183.
28. Razi M., Chan E.Y., Tooze S.A. Early endosomes and endosomal coatomer are required for autophagy. J Cell Biol 2009, 185:305-321.
29. Jin S., DiPaola R.S., Mathew R., White E. Metabolic catastrophe as a means to cancer cell death. J Cell Sci 2007, 120:379-383.
30. Friday B.B., Adjei A.A. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 2008, 14:342-346.
31. Rapisarda A., Uranchimeg B., Scudiero D.A., Selby M., Sausville E.A., Shoemaker R.H., Melillo G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 2002, 62:4316-4324.
32. Kong D., Park E.J., Stephen A.G., Calvani M., Cardellina J.H., Monks A., Fisher R.J., Shoemaker R.H., Melillo G. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res 2005, 65:9047-9055.
33. Kung A.L., Wang S., Klco J.M., Kaelin W.G., Livingston D.M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 2000, 6:1335-1340.
34. Papandreou I., Lim A.L., Laderoute K., Denko N.C. Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ 2008, 15:1572-1581.
35. Yazbeck V.Y., Buglio D., Georgakis G.V., Li Y., Iwado E., Romaguera J.E., Kondo S., Younes A. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. Exp Hematol 2008, 36:443-450.
36. Cao C., Subhawong T., Albert J.M., Kim K.W., Geng L., Sekhar K.R., Gi Y.J., Lu B. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res 2006, 66:10040-10047.
37. Balgi A.D., Fonseca B.D., Donohue E., Tsang T.C., Lajoie P., Proud C.G., Nabi I.R., Roberge M. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 2009, 4:e7124.
38. Yogalingam G., Pendergast A.M. Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J Biol Chem 2008, 283:35941-35953.
39. Basciani S., Vona R., Matarrese P., Ascione B., Mariani S., Cauda R., Gnessi L., Malorni W., Straface E., Lucia M.B. Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells. FEBS Lett 2007, 581:5897-5903.
40. White E., DiPaola R.S. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009, 15:5308-5316.
41. Chen N., Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta 2009, 1793:1516-1523.
42. Carew J.S., Nawrocki S.T., Kahue C.N., Zhang H., Yang C., Chung L., Houghton J.A., Huang P., Giles F.J., Cleveland J.L. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007, 110:313-322.
43. Leu J.I., Pimkina J., Frank A., Murphy M.E., George D.L. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 2009, 36:15-27.
44. Korolchuk V.I., Mansilla A., Menzies F.M., Rubinsztein D.C. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 2009, 33:517-527.
45. Sosman J.A., Puzanov I., Atkins M.B. Opportunities and obstacles to combination targeted therapy in renal cell cancer. Clin Cancer Res 2007, 13:764s-769s.
46. Patel P.H., Chadalavada R.S., Chaganti R.S., Motzer R.J. Targeting von Hippel-Lindau pathway in renal cell carcinoma. Clin Cancer Res 2006, 12:7215-7220.
47. Farmer H., McCabe N., Lord C.J., Tutt A.N., Johnson D.A., Richardson T.B., Santarosa M., Dillon K.J., Hickson I., Knights C., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005, 434:917-921.
48. Sutphin P.D., Chan D.A., Li J.M., Turcotte S., Krieg A.J., Giaccia A.J. Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells. Cancer Res 2007, 67:5896-5905.
49. Turcotte S., Chan D.A., Sutphin P.D., Hay M.P., Denny W.A., Giaccia A.J. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008, 14:90-102.
50. Beevers C.S., Chen L., Liu L., Luo Y., Webster N.J., Huang S. Curcumin disrupts the mammalian target of rapamycin-raptor complex. Cancer Res 2009, 69:1000-1008.
51. Park M.A., Zhang G., Martin A.P., Hamed H., Mitchell C., Hylemon P.B., Graf M., Rahmani M., Ryan K., Liu X., et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 2008, 7:1648-1662.
52. Li J., Qin Z., Liang Z. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in human U251 glioma cells. BMC Cancer 2009, 9:215.
53. Hoyer-Hansen M., Bastholm L., Szyniarowski P., Campanella M., Szabadkai G., Farkas T., Bianchi K., Fehrenbacher N., Elling F., Rizzuto R., et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell 2007, 25:193-205.
54. Kanzawa T., Zhang L., Xiao L., Germano I.M., Kondo Y., Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 2005, 24:980-991.
55. Meley D., Bauvy C., Houben-Weerts J.H., Dubbelhuis P.F., Helmond M.T., Codogno P., Meijer A.J. AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 2006, 281:34870-34879.
56. Buzzai M., Jones R.G., Amaravadi R.K., Lum J.J., DeBerardinis R.J., Zhao F., Viollet B., Thompson C.B. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007, 67:6745-6752.
57. Kim D., Cheng G.Z., Lindsley C.W., Yang H., Cheng J.Q. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. Curr Opin Investig Drugs 2005, 6:1250-1258.
58. Simone C. Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. Autophagy 2007, 3:468-471.